Learning About Different Treatment Approaches For Acute Lymphoblastic Leukemia

Speciality: Hematology

Description:

A warm welcome to all the medical professionals in this interesting learning session on different treatment approaches of Acute lymphoblastic leukemia.

In this webinar, a panel discussion would take place involving experts like Dr. Ng Chin Hin, A/Prof. Chieh-Lin Teng, Prof. Eric Tse, Clinical Professor, and Dr. Pavan Kumar Boyella to share the important facts associated with the treatment approaches of Acute lymphoblastic leukemia.

Acute Lymphoblastic Leukemia (ALL) is a cancer of the blood and bone marrow that progresses rapidly without treatment. It can reoccur after being in remission from previous treatment. It has been noted that refractory ALL did not respond to treatment indicating the previous treatments did not kill enough leukemia cells (blasts) to reach a complete remission.

Treatment approaches like combination chemotherapy, tyrosine kinase inhibitor therapy or drugs like Inotuzumab can be used for treating patients of acute lymphoblastic leukemia. Patients with relapsed/refractory B-ALL have poor outcomes but the use of Inotuzumab may improve it.

Therefore,  you are going to have an overall knowledge regarding management of ALK positive lung cancer. Listen to the webinar, grab the knowledge that is shared and follow HiDoc for more such interesting webinar sessions.
 

See More Webinars @ Hidoc Webinars